Evidence map›Paper›PMID 40271061›Full record

ReviewFrontiers in pharmacology2025

Xinyi Zhang, Meiqi Liu, Xiaozhuang Zhang, Lengleng Ma, Shiyi Song, Meitong Pan, Shumin Huang, Weichao Ren, Wei Ma

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Pharmaceutics · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xinyi ZhangCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Meiqi LiuCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Xiaozhuang ZhangCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Lengleng MaCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Shiyi SongCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Meitong PanCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Shumin HuangCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Weichao RenCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Wei MaCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aster tataricus L.f.comprehensive utilizationethnopharmacologypharmacological activityphytochemistrytoxicology

Identifiers

PMID40271061
PMCPMC12014666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.